Soleman J, Constantini S, Roth J
Childs Nerv Syst. 2024; 40(10):3179-3187.
PMID: 39215810
PMC: 11511734.
DOI: 10.1007/s00381-024-06598-z.
Deng Z, Luo J, Ma J, Jin Y, Yu Y
Aging (Albany NY). 2024; 16(11):9518-9546.
PMID: 38819225
PMC: 11210255.
DOI: 10.18632/aging.205881.
Hassan M, Al-Zurfi A, Abed M, Ahmed K
Sci Rep. 2024; 14(1):11977.
PMID: 38796531
PMC: 11128012.
DOI: 10.1038/s41598-024-61444-1.
Vaz-Salgado M, Garcia B, Perez I, Munarriz B, Domarco P, Gonzalez A
Clin Transl Oncol. 2024; 26(11):2856-2865.
PMID: 38662171
PMC: 11467015.
DOI: 10.1007/s12094-024-03456-x.
Toader C, Eva L, Costea D, Corlatescu A, Covache-Busuioc R, Bratu B
Brain Sci. 2023; 13(12).
PMID: 38137148
PMC: 10741942.
DOI: 10.3390/brainsci13121700.
Reasoning and causal inference regarding surgical options for patients with low-grade gliomas using machine learning: A SEER-based study.
Zhu E, Shi W, Chen Z, Wang J, Ai P, Wang X
Cancer Med. 2023; 12(22):20878-20891.
PMID: 37929878
PMC: 10709720.
DOI: 10.1002/cam4.6666.
Positive regulators of T cell functions as predictors of prognosis and microenvironment characteristics of low-grade gliomas.
Li Y, Feng Y, Luo F, Peng G, Li Y
Front Immunol. 2023; 13:1089792.
PMID: 36726969
PMC: 9885161.
DOI: 10.3389/fimmu.2022.1089792.
Prognostic Factors of Low-Grade Gliomas in Adults.
Deacu M, Popescu S, Docu Axelerad A, Topliceanu T, Aschie M, Bosoteanu M
Curr Oncol. 2022; 29(10):7327-7342.
PMID: 36290853
PMC: 9600247.
DOI: 10.3390/curroncol29100576.
Hepcidin is upregulated and is a potential therapeutic target associated with immunity in glioma.
Dong T, Zhang B, Zhang R, Wang C, Liu X, Wang F
Front Oncol. 2022; 12:963096.
PMID: 36237302
PMC: 9552819.
DOI: 10.3389/fonc.2022.963096.
Zebrafish Models of Paediatric Brain Tumours.
Basheer F, Dhar P, Samarasinghe R
Int J Mol Sci. 2022; 23(17).
PMID: 36077320
PMC: 9456103.
DOI: 10.3390/ijms23179920.
Molecular Aberrations Stratify Grade 2 Astrocytomas Into Several Rare Entities: Prognostic and Therapeutic Implications.
Interno V, Triggiano G, De Santis P, Stucci L, Tucci M, Porta C
Front Oncol. 2022; 12:866623.
PMID: 35756624
PMC: 9226400.
DOI: 10.3389/fonc.2022.866623.
Piecing Together a Puzzle of Exceptional Lesions: A Retrospective Study of a Potpourri of 160 Space-Occupying Lesions of the Central Nervous System.
Gore C, Mishra P, Rashmi R, Chugh A
Cureus. 2022; 14(3):e23585.
PMID: 35495013
PMC: 9045842.
DOI: 10.7759/cureus.23585.
Eloquent Lower Grade Gliomas, a Highly Vulnerable Cohort: Assessment of Patients' Functional Outcome After Surgery Based on the LoG-Glio Registry.
Coburger J, Onken J, Rueckriegel S, von der Brelie C, Nadji-Ohl M, Forster M
Front Oncol. 2022; 12:845992.
PMID: 35311092
PMC: 8927728.
DOI: 10.3389/fonc.2022.845992.
Development and Validation of an Efficient MRI Radiomics Signature for Improving the Predictive Performance of 1p/19q Co-Deletion in Lower-Grade Gliomas.
Kha Q, Le V, Hung T, Le N
Cancers (Basel). 2021; 13(21).
PMID: 34771562
PMC: 8582370.
DOI: 10.3390/cancers13215398.
Mathematical Modeling and Mutational Analysis Reveal Optimal Therapy to Prevent Malignant Transformation in Grade II IDH-Mutant Gliomas.
Aoki K, Suzuki H, Yamamoto T, Yamamoto K, Maeda S, Okuno Y
Cancer Res. 2021; 81(18):4861-4873.
PMID: 34333454
PMC: 9635454.
DOI: 10.1158/0008-5472.CAN-21-0985.
Role of Temozolomide Regimen on Survival Outcomes in Molecularly Stratified WHO Grade II Gliomas: A Systematic Review.
Ghaffari-Rafi A, Ghaffari-Rafi S, Leon-Rojas J
Asian J Neurosurg. 2021; 16(1):14-23.
PMID: 34211862
PMC: 8202389.
DOI: 10.4103/ajns.AJNS_186_20.
The Impact of an Ultra-Early Postoperative MRI on Treatment of Lower Grade Glioma.
Pala A, Durner G, Braun M, Schmitz B, Wirtz C, Coburger J
Cancers (Basel). 2021; 13(12).
PMID: 34200923
PMC: 8230433.
DOI: 10.3390/cancers13122914.
The Prognostic Role and Nomogram Establishment of a Novel Prognostic Score Combining with Fibrinogen and Albumin Levels in Patients with WHO Grade II/III Gliomas.
Jia T, Zhang R, Kong F, Zhang Q, Xi Z
Int J Gen Med. 2021; 14:2137-2145.
PMID: 34093034
PMC: 8169085.
DOI: 10.2147/IJGM.S303733.
Spiritual well-being and its association with health-related quality of life in primary brain tumor patients.
Randazzo D, McSherry F, Herndon 2nd J, Affronti M, Lipp E, Miller E
Neurooncol Pract. 2021; 8(3):299-309.
PMID: 34055377
PMC: 8153806.
DOI: 10.1093/nop/npaa084.
MRI-Based Radiomics and Radiogenomics in the Management of Low-Grade Gliomas: Evaluating the Evidence for a Paradigm Shift.
Habib A, Jovanovich N, Hoppe M, Ak M, Mamindla P, Colen R
J Clin Med. 2021; 10(7).
PMID: 33915813
PMC: 8036428.
DOI: 10.3390/jcm10071411.